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Purpose/Objective: European authorities and scientific 
societies have advised that patient safety be analyzed and 
adequately managed. Thus, we present a set of tools and 
measures we studied in order to reinforce patient safety in 
Intraoperative electron radiotherapy (IOERT). 
Materials and Methods: We performed a Failure mode and 
effect analysis (FMEA) which was used to centralize all the 
information regarding patient safety in IOERT. Safety 
elements included tools such as in vivo dosimetry in 40 valid 
cases, statistical process control (SPC) of electron beam 
monitoring, checklists design and implementation, and other 
insights unveiled by the FMEA like the necessity for checking 
several actions taken by involved professionals. In vivo 
dosimetry was performed with reinforced MOSFETs model TN-
502RDM-H (Best Medical Canada Ltd., Ottawa, Canada). 
Electron beam monitoring was carried out with the daily 
checking device, Daily QA Check 1090 (Sun Nuclear 
Corporation, Melbourne, USA), which controlled our Elekta 
Precise linac (Elekta AB, Stockholm, Sweden) used for the 
IOERT treatments. Our checklists were related to procedures 
and materials managed by anesthesiologists, surgeons, 
radiation oncologists, nurses, radiation therapists, and 
medical physicists. They were divided in blocks and timeouts. 
Results: The FMEA was a very fruitful tool to identify all 
potential risks and allocate measures in order to reduce such 
risks and reinforce patient safety. In vivo dosimetry 
confirmed our treatments as correct, with a delivered 
measured absorbed dose of 93.8% on average (with a 
standard deviation of 6.7%), compared to an expected dose 
to the tumor bed between the prescribed dose (90%) and the 
maximum dose (100%). SPC led to uneasy-to-implement 
conclusions due to its high sensitivity compared to linac 
output fluctuations. As an example, absorbed dose delivered 
with 9 MeV beams would require to be adjusted one quarter 
of the times they are checked in order to achieve a feasible 
control band of 1.15% calculated with their SPC. Checklists 
were feasible and easy to write, but require a strong 
commitment of the multidisciplinary team to be operative, 
namely the strict fulfillment of blocks at timeouts. Other 
necessary elements are double checking of human decisions, 
also easy to implement, and requests for automation 
whenever possible, which need engagement of companies to 
be solved. 
 
 
 
Conclusions: FMEA can be the main tool to identify 
opportunities for patient safety reinforcing, and can produce 
a central board to which fit risk reduction elements and 
actions. As examples, these measures and tools can be an in 
vivo dosimetry program, checklists, checking of human 
decision-making, and automation of several processes. 
Nevertheless, SPC needs further research before being 
integrated. This approach can be extended to other 
radiotherapy procedures. 
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Purpose/Objective: The increasingly attractive stereotactic 
body radiation therapy (SBRT) for stage I lung cancer is 
always accompanied by a large amount of monitor units (MU), 
particularly with a high dose fraction scheme. The study aims 
to find the optimal planning parameters in the treatment 
planning system optimizer to get the lowest monitor unit 
(MU) in lung SBRT. 
Materials and Methods: Fourteen patients suffered from 
peripheral or central stage I Non-Small Cell Lung Cancer 
(NSCLC) were enrolled. The upper objective of planning 
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target volume (UO-PTV) and two other MU constraining 
objectives (strength and max MU) in the optimizer were 
adjusted to investigate their effects on MU numbers, target 
coverage and organs at risk (OARs) sparing. Firstly, the UO-
PTV (with low, medium and high priority) was compared to 
find the lowest MU and superior OARs sparing; Secondly, the 
effect of strength (settings were 25, 50, 75 and 100) on the 
MU numbers was investigated based on the beneficial UO-PTV 
setting; Finally, the feasible priority and strength settings 
were then employed to investigate the impact of max MU 
(settings were 25%, 50%, 75%, 85%, 100%) on the MU numbers. 
Results: We found that the planning parameters in the 
optimizer influenced the MU numbers in a priority, strength 
and max MU-dependent manner. The MU numbers displayed a 
decreasing trend with the UO-PTV increasing. The MU 
numbers with low, medium and high priority for the UO-PTV 
were 428±54, 312±48 and 258±31 MU/Gy, respectively. The 
high priority setting for UO-PTV also spared the heart and 
cord while maintaining comparable PTV coverage than the 
low and medium priority group. The strength and max MU 
settings in the MU constraining objective also influenced the 
MU numbers. The MU numbers tended to decrease with the 
strength increasing and max MU setting decreasing. With the 
maximum strength of 100, the MU numbers reached its 
minimum while maintaining comparable or improved dose to 
the normal tissues. It was also found that the MU numbers 
continued to decline at 85% and 75% max MU setting, but no 
longer to decrease at 50% and 25%. Combined with the high 
priority for UO-PTV and MU constraining objectives, the MU 
numbers can be decreased to 223±26 MU/Gy. 
 
 
 
Conclusions: The priority of UO-PTV, MU constraining 
objective in the optimizer impact on the MU numbers in lung 
SBRT. Giving high priority to the UO-PTV, setting the strength 
to 100 and the max MU to 50% in the MU objective achieves 
the lowest MU numbers while maintaining comparable or 
improved OAR sparing. 
